Dynavax Technologies
DVAX
#4839
Rank
โ‚น167.82 B
Marketcap
โ‚น1,429
Share price
0.00%
Change (1 day)
16.99%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -โ‚น2.79 Billion

According to Dynavax Technologies 's latest financial reports the company's current earnings are โ‚น0.33 Billion. In 2024 the company made an earning of โ‚น3.47 Billion, an increase over its 2023 earnings that were of โ‚น0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น2.79 Billion-180.28%
2024 โ‚น3.47 B1475.31%
2023 โ‚น0.22 B-99.2%
2022 โ‚น27.70 B238.78%
2021 โ‚น8.17 B-257.89%
2020 -โ‚น5.19 Billion-58.58%
2019 -โ‚น12.51 Billion-9.32%
2018 -โ‚น13.8 Billion60.44%
2017 -โ‚น8.6 Billion-15.8%
2016 -โ‚น10.21 Billion4.22%
2015 -โ‚น9.8 Billion16.54%
2014 -โ‚น8.41 Billion37.09%
2013 -โ‚น6.14 Billion
2010 -โ‚น4.39 Billion214.85%
2009 -โ‚น1.4 Billion-37.33%
2008 -โ‚น2.23 Billion-66.07%
2007 -โ‚น6.56 Billion16.92%
2006 -โ‚น5.61 Billion170.36%
2005 -โ‚น2.08 Billion33.39%
2004 -โ‚น1.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.092 T-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น760.17 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น175.56 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น911.57 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.129 T-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.207 T-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น859.65 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
โ‚น1.90 B-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น198.43 B-6,450.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel